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surrogates or the actual tumor position. Corrections are 
usually limited to translations, and rotational errors, shape 
change and intra-fractional changes are not corrected for. 
For targets with a large day-to-day shape variation, or in case 
of multiple targets with differential motion, generous safety 
margins have to be used that partly undo the healthy tissue 
sparing properties of modern radiation techniques such as 
IMRT and VMAT. Adaptive radiotherapy (ART), e.g. with a 
Plan-of-the-Day (PotD) strategy has been proposed to 
overcome this problem. Guidelines for proper selection of 
patients that need a replanning (e.g. lung, rectum), or 
implementation of a more labour-intensive PotDworkflow for 
groups of patients (e.g. cervix, bladder) have been major 
research topics in recent years.  
In this presentation, an overview will be given of current 
clinical implementations of PotD strategies in literature. The 
library-based PotD procedure as implemented at Erasmus MC 
for cervical cancer patients will be discussed in more detail. 
For these patients, a plan library contains 2 or 3 VMAT plans 
adequate for target shapes and positions corresponding to 
smaller and larger bladder volumes. Every treatment day, the 
best fitting plan is selected based on an in-room acquired 
cone beam CT scan, showing internal anatomy and markers 
implanted around the primary tumor. The recent PotD 
implementation in our record & verify system has pathed the 
way for a more wide-spread application of safe and efficient 
delivery of library-based PotD strategies, and for more 
advanced library-based approaches including dynamic plan-
library updates. 
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The clinical implementation of magnetic resonance image-
guided radiation therapy (MR-IGRT) has enabled the daily 
visualization of internal soft-tissue anatomy with the patient 
in the treatment position. The information provided by the 
daily MR, which may not be available in some other online 
imaging modalities such as cone-beam CT, has allowed us to 
evaluate the impact of geometric variations in the patient on 
the planned versus delivered dose on a day to day basis. The 
availability of daily volumetric MR images, in combination 
with software tools integrated into the MR-IGRT system, and 
independent quality assurance tools for online patient-
specific QA, has allowed for clinical use of online adaptive 
MR-IGRT since September 2014.  
We report on the first year of clinical experience with online 
treatment adaptation for over 45 patients treated to various 
sites including abdomen, pelvis, and thorax, having received 
more than a total of 150 adapted fractions. Here we describe 
the clinical implementation and workflow for online adaptive 
MR-IGRT, provide details on decision criteria for daily plan 
adaptation, and discuss and compare an online plan 
adaptation approach to a plan library approach where the 
plan of the day is selected from a group of plans based on 
previous patient anatomy. We also discuss limitations of 
current techniques and future improvements. 
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Purpose or Objective: The clinical target volume (CTV) in 
rectal cancer is subject to considerable shape deformations 
due to rectal and bladder filling changes, which require large 
planning target volume (PTV) margins when conventional 
correction strategies based on bony anatomy are used.  
To mitigate errors introduced by shape variations, the library 
of plans (LoP) approach has been successfully applied for 
cervical and bladder cancer. For those sites, libraries were 
created by interpolation of structures of interest defined on 
CT scans in the full and empty bladder state. However, for 
rectal patients this approach is not feasible, as a major 
source of uncertainty is not bladder, but rectal filling.  
The purpose of this study was therefore to develop an 
alternative method for generating structures for a LoP for 
rectal cancer and to investigate its potential for PTV margin 
reduction. 
 
Material and Methods: The method proposed is based on 3D 
population statistics of the shape variation of the rectum 
CTV, rather than patient specific data derived from several 
CT scans, allowing the use of only a single planning CT scan 
for structure generation. The population statistics were 
derived from shape variation data of thirty three short course 
radiotherapy (SCRT) patients with daily repeat scans on 
which the rectum CTV was delineated. Shape variations were 
defined as standard deviations of (local) perpendicular 
displacements of the CTV surface, using each patient’s 
planning CT scan as reference.  
The LoP CTVs were created by expanding or contracting the 
planning CTV perpendicular to its surface, proportional to the 
local statistics of shape variation of the population and a 
global scaling factor. The scaling factor was tuned such that 
the largest distance between CTVs was 1 cm. Five CTVs were 
created; the original CTV, two smaller (max -1, -2 cm) and 
two larger CTVs (max +1, +2 cm).  
To determine the potential of this method, residual errors 
were calculated by using the most optimal CTV from the 
library as a reference in computing the shape variation 
statistics, rather than the original planning CTV. 
Subsequently, margins were computed for both the 
conventional and LoP strategy, using a modified version of 
the van Herk recipe. 
 
Results: An example of the constructed CTV structures is 
depicted in figure 1a. The original CTV is the middle one; two 
larger and two smaller CTVs were created using population 
statistics. Figures 1c and 1d show the required PTV margin 
for a conventional and a LoP approach, respectively. The 
difference between the two methods is shown in Figure 1b. 
The largest reduction was found in the upper anterior part of 
the CTV: 1.5 cm (≈ 40%). 
 
Conclusion: We have successfully developed a LoP strategy 
for rectum patients that uses population statistics and 
scalable expansions, thereby only requiring a single CT scan, 
as opposed to the current methods for cervix and bladder. 
Analysis of the residual errors has shown that a potential 
margin reduction of 40% is possible with this approach. 
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Debate: We don’t need better dose calculation, it’s doing 
more bad than good  
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Advanced dose calculation algorithms have demonstrated 
excellent performance against measurements for complex 
treatments and heterogeneous phantoms. Thus, it is natural 
to consider those as the best candidates for treatment 
planning. Because the dose calculation is more accurate, so 
will be the treatment and its outcome improved. This seems 
intuitively obvious. 
However, a broader view on our clinical practice may temper 
this conclusion. In our clinical practice, we are using dose 
prescriptions from past experience that was typically based 
on less accurate dose calculation algorithms. Also, we are 
using safety margins for geometrical uncertainties that are 
based on hypothesis that simplify considerably the physics of 
dose deposition, but yet seem to provide adequate coverage 
and safety for the majority of the patients. 
We will show during this debate that changing the dose 
calculation algorithm considering our present practice will 
not necessary have a positive impact for the patients. 
Therefore, the introduction of such algorithms in clinics 
should be made cautiously. 
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Debate: Are we precisely inaccurate in our adaption?  
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This debate will critically discuss recent developments in 
adaptive radiotherapy (ART). Adaptive radiotherapy is being 
introduced in many departments nowadays and one of the 
main question is if there is sufficient evidence to safely do 
so?  
In the debate, the inaccuracies of the process will be 
discussed profoundly. What is the accuracy of the process as 
a whole? Do delineation errors and dose calculation errors 
still make ART really worth the effort? Or can these errors 
safely be corrected for?  
Another aspect that will be discussed is risk management. 
Procedures are often not supported by software released for 
this purpose. In case of e.g. plan selection, different manual 
steps are made which are probably prone to human errors. 
What is the impact of these human errors? On the other 
hand, do we really have to wait for optimal software to be 
release and keep patients treated in a sub-optimal manner?  
Last but not least is the lack of sufficient knowledge on 
tumor spread e.g. in the case of gynecological tumors. If we 
reduce the treatment area, aren't we going to miss our 
target? Will this in the end increase local relapse rates 
instead of reducing toxicity? From a different point of view it 
can be argumented that we will never get knowledge of the 
exact tumor location if we keep treating patients with a (too) 
large safety margin. 
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Debate: Moving away from 2 Gray: are we ready for a 
paradigm shift?  
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A significant proportion of curative schedules still use 
fraction sizes ≤2.0 Gy, mostly on a once-daily basis five times 
per week. These practices are likely to diminish further over 
the next 10 years, driven independently by advances in 
biology and physics. Although randomised trials in the 1980s 
and ‘90s confirmed squamous carcinomas of the head and 
neck and bronchus to be relatively insensitive to fraction size 
compared to the dose-limiting late-reacting normal tissues, it 
is now well established that adenocarcinomas of the breast 
and prostate share comparable, or perhaps greater, 
sensitivity to fraction size than the dose-limiting late normal 
tissues. Hypofractionation is increasingly adopted as a 
standard of care for women with breast cancer, and practices 
are changing for men with prostate cancer too, diseases 
account for 28% and 17%, respectively, of all UK radiotherapy 
courses. High dose brachytherapy and novel external beam 
techniques exclude adjacent normal tissues from the high 
dose zone so effectively that prescribed dose is limited 
mainly, if not exclusively, by tissues in the paths of entry and 
exit beams. The impact of stereotactic radiotherapy in 
common cancers remains to be established, but early results 
for early stage lung cancer look encouraging, particularly 
when the benefits of acceleration are factored in. There is 
therefore ample justification to support a prediction that 
accelerated hypofractionation will be a standard of care for 
the majority of curative treatments well before 2025. 
 
 
